Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
Evaluation of miscellaneous heat shock protein (Hsp90) inhibitors using different methodologies
Author(s): Mahmoud A. Al-Sha’erIn this review, 100 diverse chemical derivatives were either designed, synthesized or naturally screened and tested as Hsp90 inhibitors, miscellaneous derivatives were synthesized that represent different scaffolds. Anti-Hsp90 activities of these compounds were examined and diverse activities were observed. Although Hsp90 inhibition had activities against cancerous cell line, there is no Hsp90 inhibitor as anticancer FDA approved drug yet, however some clinically investigated Hsp90 inhibitors are in phase I and phase II. Hsp90 inhibitors could act as a new strategy for treatment of cancer as a chronic disease rather than using typically aggressive chemotherapeutic agents.
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 25868
Der Pharma Chemica received 25868 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
DOWNLOADS
